Ch 17 Infectious Diseases and Vaccines Flashcards

(30 cards)

1
Q

Emerging Disease

A

something new, not previously observed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

example of an emerging disease

A
  • New strains of influenza

- SARS-CoV-2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Re-emerging disease

A

something old, coming back again

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

example of a re-emerging disease

A

measles in the US

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What factors can increase the likelihood of emerging diseases?

A
  • increases in international travel
  • mass distribution of contaminated food
  • improper antibiotic use
  • spread of humans into previously uninhabited areas, introducing to novel microbes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What factors can increase the likelihood of re-emerging diseases?

A
  • combinations of diseases (HIV and TB)

- laxity in vaccination program adherence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Example of re-emergence combinations of diseases

A

HIV and TB

  • in the 90s, it was thought that TB would soon disappear as a problem in the US
  • the AIDS epidemic resulted in a large increase in immunocompromised individuals, who subsequently became sick with Mycobacterium
  • regular treatment of immunocompromised patients with antibiotics resulted in resistant TB strains
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Example of re-emergence of disease due to laxity in vaccination program adherence

A
  • diptheria in Soviet Union
  • Whooping cough in US
  • Measles in US
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Passive immunization

A

delivery of preformed antibody

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Protective immunity can be achieved by ___ or ____ immunization.

A

active;passive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Conditions that warrant passive immunization

A
  • immune deficiency
  • toxin or venom exposure with immediate threat to life
  • exposure to pathogens that can cause death faster than an effective immune response can develop
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Why can passive immunization lead to Type I or III hypersensitivities?

A

Ab agents are typically made from animals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the goal of vaccination?

A

to provide a primary exposure to a safer form of an antigen, either by exposing to a protein/polysaccharide or by exposure to a weakened (attenuated) form of the pathogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

The goal of vaccination is to provide a ____ ______ to a safer form of an antigen.

A

primary exposure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Vaccinations provide _____ ______ without the potential negative consequences of a natural infection.

A

active immunity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Side effects of vaccines, when present, are usually indicators of ____ _____ to a novel pathogen

A

immune reaction

17
Q

Herd immunity

A

resistance to the spread of an infectious disease within a population that is based on pre-existing immunity of a high proportion of individuals as a result of previous infection or vaccination

18
Q

Basic reproductive number values

A

the infectibility of a disease

19
Q

Simplified calculation for finding the percentage of people that need active immunity against an agent to achieve herd immunity is based on the:

A

basic reproduction number (R0) of the agent

20
Q

How do you calculate the approximate level of herd immunity required based on the R0 value?

A

Herd immunity= 1 - 1/R0

21
Q

Once a vaccine is approved, what other safety measures are in place to ensure that vaccine is still as safe as possible?

A

after approval by the FDA, every lot of vaccine must be tested before release and manufacturing facilities are checked regularly for compliance of safety and manufacturing procedures

22
Q

Live attenuated vaccine components

A

pathogens are weakened by continuous growth in conditions outside of their ‘ideal’

23
Q

Pros of live attenuated vaccines

A
  • retain their ability to replicate, promoting both humoral and cell-mediated responses
  • often do not need boosters
24
Q

Cons of live attenuated vaccines

A
  • may mutate back (revert) to pathogenic form
  • may have more side-effect complications
  • may also require a “cold chain” for stability during transport
25
Inactivated vaccine components
heated or chimically treated to inactivate pathogen
26
Pros of inactivated vaccines
- no reversion to pathogenic form | - often more stable/easy to store and transport
27
Cons of inactivated vaccines
- require booster shots - don't replicate in host, so often don't induce cell-mediated immunity well (humoral only) - possible chemical exposures/adjuvants often required - potentially dangerous if not all pathogen is killed/inactivated
28
Subunit vaccine components
- use purified macromolecules derived from pathogen - inactivated exotoxins/toxoids - inactivated capsular polysaccharides - inactivated surface glycoproteins (or recombinant protein Ag_
29
Pros/cons of subunit vaccines
similar to those of innactivated vaccines
30
Conjugate/multivalent subunit vaccines
some molecules aren't strong enough Ags on their won to stimulate a good response - couple them with something else that is (conjugate) - deliver them in a mixture of proteins (multivalent) - have to deliver Ag into cells for presentation in MHC I